189 related articles for article (PubMed ID: 8129761)
1. High frequency of silent inflammatory bowel disease in spondylarthropathy.
Leirisalo-Repo M; Turunen U; Stenman S; Helenius P; Seppälä K
Arthritis Rheum; 1994 Jan; 37(1):23-31. PubMed ID: 8129761
[TBL] [Abstract][Full Text] [Related]
2. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects.
Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Elewaut D
J Rheumatol; 1995 Dec; 22(12):2273-8. PubMed ID: 8835561
[TBL] [Abstract][Full Text] [Related]
3. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies].
Mielants H; Veys EM
Verh K Acad Geneeskd Belg; 1996; 58(2):93-116. PubMed ID: 8768479
[TBL] [Abstract][Full Text] [Related]
4. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint.
Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Gyselbrecht L; Elewaut D
J Rheumatol; 1995 Dec; 22(12):2279-84. PubMed ID: 8835562
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.
Turkcapar N; Toruner M; Soykan I; Aydintug OT; Cetinkaya H; Duzgun N; Ozden A; Duman M
Rheumatol Int; 2006 May; 26(7):663-8. PubMed ID: 16136311
[TBL] [Abstract][Full Text] [Related]
6. Subclinical involvement of the gut in undifferentiated spondylarthropathies.
Mielants H; Veys EM; Cuvelier C; De Vos M
Clin Exp Rheumatol; 1989; 7(5):499-504. PubMed ID: 2591124
[TBL] [Abstract][Full Text] [Related]
7. Ileocolonoscopy in seronegative spondylarthropathy.
De Vos M; Cuvelier C; Mielants H; Veys E; Barbier F; Elewaut A
Gastroenterology; 1989 Feb; 96(2 Pt 1):339-44. PubMed ID: 2637670
[TBL] [Abstract][Full Text] [Related]
8. The HLA B27 antigen-spondylarthropathy association. Impact on clinical expression.
Saraux A; de Saint-Pierre V; Baron D; Valls I; Koreichi D; Youinou P; Le Goff P
Rev Rhum Engl Ed; 1995; 62(7-8):487-91. PubMed ID: 8574611
[TBL] [Abstract][Full Text] [Related]
9. Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondyloarthropathy--a prospective study.
Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; Maertens M; Joos R
J Rheumatol; 1993 Sep; 20(9):1567-72. PubMed ID: 8164217
[TBL] [Abstract][Full Text] [Related]
10. Concordance between abdominal scintigraphy using technetium-99m hexamethylpropylene amine oxime-labelled leucocytes and ileocolonoscopy in patients with spondyloarthropathies and without clinical evidence of inflammatory bowel disease.
El Maghraoui A; Dougados M; Freneaux E; Chaussade S; Amor B; Breban M
Rheumatology (Oxford); 1999 Jun; 38(6):543-6. PubMed ID: 10402075
[TBL] [Abstract][Full Text] [Related]
11. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects.
Mielants H; Veys EM; De Vos M; Cuvelier C; Goemaere S; De Clercq L; Schatteman L; Elewaut D
J Rheumatol; 1995 Dec; 22(12):2266-72. PubMed ID: 8835560
[TBL] [Abstract][Full Text] [Related]
12. Clinical, radiological, and laboratory findings in Lebanese spondylarthropathy patients according to HLA-B27 status.
Awada H; Abi-Karam G; Baddoura R; Okais J; Attoui S
Joint Bone Spine; 2000; 67(3):194-8. PubMed ID: 10875317
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class II antigen (HLA-DR) expression by ileal epithelial cells in patients with seronegative spondylarthropathy.
Cuvelier C; Mielants H; De Vos M; Veys E; Roels H
Gut; 1990 May; 31(5):545-9. PubMed ID: 2351304
[TBL] [Abstract][Full Text] [Related]
14. HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis.
Mielants H; Veys EM; Cuvelier C; De Vos M; Botelberghe L
J Rheumatol; 1985 Apr; 12(2):294-8. PubMed ID: 3875721
[TBL] [Abstract][Full Text] [Related]
15. Ileocolonoscopic findings in patients with ankylosing spondylitis: a single center retrospective study.
Ahn SM; Kim YG; Bae SH; Lim DH; Hong S; Park SH; Lee CK; Yoo B
Korean J Intern Med; 2017 Sep; 32(5):916-922. PubMed ID: 28797160
[TBL] [Abstract][Full Text] [Related]
16. Review article: joint involvement in inflammatory bowel disease.
De Vos M
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():36-42. PubMed ID: 15352892
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
Klingberg E; Strid H; Ståhl A; Deminger A; Carlsten H; Öhman L; Forsblad-d'Elia H
Arthritis Res Ther; 2017 Feb; 19(1):21. PubMed ID: 28148281
[TBL] [Abstract][Full Text] [Related]
18. Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study.
Mielants H; Veys EM; Goemaere S; Goethals K; Cuvelier C; De Vos M
J Rheumatol; 1991 Oct; 18(10):1542-51. PubMed ID: 1765980
[TBL] [Abstract][Full Text] [Related]
19. Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease.
Dekker-Saeys BJ; Meuwissen SG; Van Den Berg-Loonen EM; De Haas WH; Agenant D; Tytgat GN
Ann Rheum Dis; 1978 Feb; 37(1):33-5. PubMed ID: 629601
[TBL] [Abstract][Full Text] [Related]
20. The role of gut inflammation in the pathogenesis of spondyloarthropathies.
Mielants H; De Vos M; Cuvelier C; Veys EM
Acta Clin Belg; 1996; 51(5):340-9. PubMed ID: 8950841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
